BIOMAT Database Logo BIOMAT Database Logo

Macrophage activation syndrome as the initial manifestation of systemic onset juvenile idiopathic arthritis. 2001

E Cuende, and J C Vesga, and L B Pérez, and M T Ardanaz, and J Guinea

UI MeSH Term Description Entries
D007154 Immune System Diseases Disorders caused by abnormal or absent immunologic mechanisms, whether humoral, cell-mediated, or both. Immune Disorders,Immune System Disorders,Immunologic Diseases,Diseases of Immune System,Immune Diseases,Immunological Diseases,Disease, Immune,Disease, Immune System,Disease, Immunologic,Disease, Immunological,Disorder, Immune System,Immune Disease,Immune Disorder,Immune System Disease,Immune System Disorder,Immunologic Disease,Immunological Disease
D008262 Macrophage Activation The process of altering the morphology and functional activity of macrophages so that they become avidly phagocytic. It is initiated by lymphokines, such as the macrophage activation factor (MAF) and the macrophage migration-inhibitory factor (MMIF), immune complexes, C3b, and various peptides, polysaccharides, and immunologic adjuvants. Activation, Macrophage,Activations, Macrophage,Macrophage Activations
D008297 Male Males
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D008775 Methylprednisolone A PREDNISOLONE derivative with similar anti-inflammatory action. 6-Methylprednisolone,Medrol,Metipred,Urbason,6 Methylprednisolone
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D001171 Arthritis, Juvenile Arthritis in children, with onset before 16 years of age. The terms juvenile rheumatoid arthritis (JRA) and juvenile idiopathic arthritis (JIA) refer to classification systems for chronic arthritis in children. Only one subtype of juvenile arthritis (polyarticular-onset, rheumatoid factor-positive) clinically resembles adult rheumatoid arthritis and is considered its childhood equivalent. Arthritis, Juvenile Chronic,Arthritis, Juvenile Idiopathic,Arthritis, Juvenile Rheumatoid,Childhood Arthritis,PCJIA,PJIA Polyarticular Juvenile Idiopathic Arthritis,Polyarticular Juvenile Idiopathic Arthritis,Polyarticular-Course Juvenile Idiopathic Arthritis,Still's Disease, Juvenile-Onset,Enthesitis-Related Arthritis, Juvenile,Juvenile Chronic Arthritis,Juvenile Idiopathic Arthritis,Juvenile Rheumatoid Arthritis,Juvenile-Onset Still Disease,Juvenile-Onset Stills Disease,Oligoarthritis, Juvenile,Polyarthritis, Juvenile, Rheumatoid Factor Negative,Polyarthritis, Juvenile, Rheumatoid Factor Positive,Psoriatic Arthritis, Juvenile,Still Disease, Juvenile-Onset,Systemic Arthritis, Juvenile,Arthritides, Childhood,Arthritis, Childhood,Arthritis, Juvenile Enthesitis-Related,Arthritis, Juvenile Psoriatic,Arthritis, Juvenile Systemic,Childhood Arthritides,Chronic Arthritis, Juvenile,Enthesitis Related Arthritis, Juvenile,Idiopathic Arthritis, Juvenile,Juvenile Arthritis,Juvenile Enthesitis-Related Arthritis,Juvenile Oligoarthritis,Juvenile Onset Still Disease,Juvenile Onset Stills Disease,Juvenile Psoriatic Arthritis,Juvenile Systemic Arthritis,Juvenile-Onset Still's Disease,Rheumatoid Arthritis, Juvenile,Still Disease, Juvenile Onset,Still's Disease, Juvenile Onset,Stills Disease, Juvenile-Onset
D013577 Syndrome A characteristic symptom complex. Symptom Cluster,Cluster, Symptom,Clusters, Symptom,Symptom Clusters,Syndromes

Related Publications

E Cuende, and J C Vesga, and L B Pérez, and M T Ardanaz, and J Guinea
[Macrophage activation syndrome and systemic onset of juvenile idiopathic arthritis].
March 2010, Anales de pediatria (Barcelona, Spain : 2003),
E Cuende, and J C Vesga, and L B Pérez, and M T Ardanaz, and J Guinea
Macrophage activation syndrome in 13 children with systemic-onset juvenile idiopathic arthritis.
May 2008, World journal of pediatrics : WJP,
E Cuende, and J C Vesga, and L B Pérez, and M T Ardanaz, and J Guinea
[Macrophage activation syndrome in Chinese children with systemic onset juvenile idiopathic arthritis].
November 2006, Zhonghua er ke za zhi = Chinese journal of pediatrics,
E Cuende, and J C Vesga, and L B Pérez, and M T Ardanaz, and J Guinea
Macrophage activation syndrome in systemic juvenile idiopathic arthritis.
December 2021, Immunological medicine,
E Cuende, and J C Vesga, and L B Pérez, and M T Ardanaz, and J Guinea
Outcome of PatientsWith Systemic Onset Juvenile Idiopathic Arthritis With Macrophage Activation Syndrome at Onset.
January 2021, Indian pediatrics,
E Cuende, and J C Vesga, and L B Pérez, and M T Ardanaz, and J Guinea
Macrophage activation syndrome in a patient with systemic onset of the juvenile idiopathic arthritis.
January 2016, Reumatologia,
E Cuende, and J C Vesga, and L B Pérez, and M T Ardanaz, and J Guinea
[Macrophage activation syndrome associated with systemic juvenile idiopathic arthritis].
January 2004, Jornal de pediatria,
E Cuende, and J C Vesga, and L B Pérez, and M T Ardanaz, and J Guinea
Systemic Juvenile Idiopathic Arthritis Complicated by Macrophage Activation Syndrome.
June 2015, Pediatric annals,
E Cuende, and J C Vesga, and L B Pérez, and M T Ardanaz, and J Guinea
Macrophage activation syndrome as the initial manifestation of severe juvenile onset systemic lupus erythematosus. Favorable response to cyclophosphamide.
January 2014, Reumatologia clinica,
E Cuende, and J C Vesga, and L B Pérez, and M T Ardanaz, and J Guinea
[A case report of macrophage activation syndrome complicated by systemic onset juvenile idiopathic arthritis].
December 2007, Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics,
Copied contents to your clipboard!